These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 1488020)

  • 21. Cisplatin-evoked DNA fragmentation in normal and cancer cells and its modulation by free radical scavengers and the tyrosine kinase inhibitor STI571.
    Wozniak K; Czechowska A; Blasiak J
    Chem Biol Interact; 2004 Apr; 147(3):309-18. PubMed ID: 15135086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Repair of cisplatin-DNA adducts in mutants for genes controlling spontaneous and induced mutagenesis in Saccharomyces cerevisiae].
    Koval'tsova SV; Chernenkov AIu; Korolev VG
    Genetika; 2007 Jan; 43(1):100-4. PubMed ID: 17333945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formation and repair of DNA interstrand cross-links in relation to cytotoxicity and unscheduled DNA synthesis induced in control and mutant human cells treated with cis-diamminedichloroplatinum(II).
    Plooy AC; van Dijk M; Berends F; Lohman PH
    Cancer Res; 1985 Sep; 45(9):4178-84. PubMed ID: 3928152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transmission and expression of mutations to nalidixic acid resistance among products of protoplast fusion crosses of Candida albicans.
    Haught MA; Sarachek A
    Mutat Res; 1985 Oct; 152(1):15-23. PubMed ID: 3900712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinogenic activity of nalidixic acid for artificial hybrids but not for natural strains of Candida albicans: evidence for the monoploidy of natural strains.
    Sarachek A
    Z Allg Mikrobiol; 1983; 23(6):385-91. PubMed ID: 6356639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of cis-platinum on human blood monocyte function in vitro.
    Nielsen H
    Cancer Immunol Immunother; 1984; 18(3):223-5. PubMed ID: 6391659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterozygosity and segregation in Candida albicans.
    Whelan WL; Partridge RM; Magee PT
    Mol Gen Genet; 1980; 180(1):107-13. PubMed ID: 7003306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reaction kinetics of cisplatin and its monoaquated species with the modulating agents (di)mesna and thiosulphate.
    Leeuwenkamp OR; Neijt JP; van der Vijgh WJ; Pinedo HM
    Eur J Cancer; 1991; 27(10):1243-7. PubMed ID: 1835593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Morphological and growth altering effects of Cisplatin in C. albicans using fluorescence microscopy.
    Kesavan C; Raghunathan M; Ganesan N
    Ann Clin Microbiol Antimicrob; 2005 Apr; 4():7. PubMed ID: 15850483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antifungal activity of nonantifungal drugs.
    Afeltra J; Verweij PE
    Eur J Clin Microbiol Infect Dis; 2003 Jul; 22(7):397-407. PubMed ID: 12884072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Murine tissues exposed to cytotoxic drugs display altered patterns of Candida albicans adhesion.
    López-Ribot JL; McVay CS; Chaffin WL
    Infect Immun; 1994 Oct; 62(10):4226-32. PubMed ID: 7927678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Recent advances in the biology of Candida].
    Odds FC
    Ann Biol Clin (Paris); 1987; 45(5):553-7. PubMed ID: 3322117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the genotoxic spectrum of cisplatin for Candida albicans.
    Sarachek A; Henderson L; Wilkens WE
    Microbios; 1992; 72(292-293):183-201. PubMed ID: 1488020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic destabilization of Candida albicans by hydroxyurea.
    Sarachek A; Henderson LA; Eddy KB
    Microbios; 1991; 65(262):39-61. PubMed ID: 2014007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinagenicity of caffeine for Candida albicans.
    Sarachek A; Henderson LA
    Mycopathologia; 1990 May; 110(2):63-76. PubMed ID: 2195351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modification of responses of Candida albicans to cisplatin by membrane damaging antimycotic agents.
    Sarachek A; Henderson LA
    Mycoses; 1991; 34(3-4):177-82. PubMed ID: 1749398
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.